Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Constellation Brands Updates Fiscal 2026 Outlook

(NYSE:STZ) Updates reported EPS guidance to $10.77 - $11.07 and comparable EPS guidance to $11.30 - $11.60 (1)

What operational or macro factors are driving the EPS outlook change, and how might they affect the company's long‑term growth prospects? What are the implications of the revised guidance on STZ's valuation multiples relative to peers like Anheuser-Busch InBev and Heineken? How does the updated FY2026 EPS guidance compare to the prior consensus estimates and what price movement might we expect?
Symbol: STZ
Earnings
13 days ago
Read more globenewswire

BPC Instruments expands into the textile sector - receives order from a global materials company

(BPC) LUND, Sweden, Sept. 2, 2025 /PRNewswire/ -- BPC Instruments AB (publ) is extending the industrial application of its BPCÂź Blue platform into the textiles & apparel sector, broadening the comp...

How might this expansion influence BPC's competitive positioning and valuation relative to peers in sustainable materials testing? What is the expected timeline and scale of the order from the global materials company, and how does it compare to BPC's existing contracts? How will the entry into the textile & apparel sector affect BPC's revenue growth and profit margins?
Symbol: BPC
Expansion
13 days ago
Read more prnewswire

Hammond Power Solutions Provides Update on U.S. Tariff Changes

(NYSE:HPS) GUELPH, Ontario, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Hammond Power Solutions Inc. (“HPS” or the “Company”) (TSX: HPS.A) has determined that the recently expanded U.S. tariffs on steel a...

How does HPS's exposure to these tariffs compare with its peers in the power solutions sector, and what mitigation strategies is the company implementing? What is the expected impact of the tariffs on HPS's revenue forecasts and stock valuation in the short to medium term? How will the expanded U.S. tariffs on steel and aluminum affect HPS's profit margins and cost structure?
Symbol: HPS
Tariffs
13 days ago
Read more globenewswire

Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million

(NASDAQ:RPRX) NEW YORK and WALTHAM, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Zenas BioPharma, Inc. (Nasdaq: ZBIO) today announced that Royalty Pharma will p...

How does this royalty arrangement compare to similar financing structures in the biotech sector and what are the potential dilution or upside risks for investors? What impact will the obexelimab funding agreement have on Zenas BioPharma’s valuation and share price volatility? How will the $300 million royalty financing deal affect Royalty Pharma’s cash flow and earnings outlook?
Symbol: RPRX
Funding
13 days ago
Read more globenewswire